☆ 4.7 Article

The combination of tetracyclines effectively ameliorates liver fibrosis via inhibition of EphB1/2

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cell Biology

Signals transduced by Eph receptors and ephrin ligands converge on MAP kinase and AKT pathways in human cancers

Andreas Lau et al.

Summary: Eph receptors and ephrin ligands play a role in various human cancers, modulating cellular processes such as proliferation, metastasis, angiogenesis, invasion, and apoptosis. The abundance of a unique subset of Eph receptors and ephrin ligands is associated with tumorigenesis, converging on MAP kinase and/or AKT/mTOR signaling pathways.

CELLULAR SIGNALLING (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neddylation of EphB1 Regulates Its Activity and Associates with Liver Fibrosis

Rongxin Li et al.

Summary: In this study, the researchers found that the expression of EphB1 is significantly increased in activated HSCs, accompanied by remarkable neddylation. This neddylation enhances the kinase activity of EphB1, promoting HSC proliferation, migration, and activation, and thus contributing to the development of liver fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities

Qiying Pei et al.

Summary: The liver is vital for metabolism and is susceptible to injuries, leading to liver fibrosis which can cause serious health issues. Effective anti-fibrotic medications are lacking, and the current approach of eliminating causes is slow and not always feasible. Understanding the mechanisms of liver fibrosis is crucial for finding new therapeutic targets. Inhibiting hepatic stellate cell activation and related signaling pathways can reverse fibrosis. This review focuses on the activation of hepatic stellate cells and targeting them or liver fibrosis signaling pathways for resolution. Additionally, new therapeutic compounds for liver fibrosis are summarized.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Cell Biology

Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis

Yang Xiao et al.

Summary: Current therapeutic strategies for NASH have been ineffective in alleviating liver fibrosis. This study used single-nucleus transcriptomics and epigenomics to characterize liver cell types during NASH development in mice and humans. The progression of hepatocyte trajectory with NASH was conserved between the two species. Hepatocytes exhibited metabolic adaptation at the NAFL stage, while at the NASH stage, a subset of hepatocytes showed enrichment in cell adhesion and migration signatures, mainly through the receptor tyrosine kinase EphB2. Knockdown of Ephb2 in hepatocytes ameliorated inflammation and fibrosis in a mouse model of NASH, suggesting EphB2 as a potential therapeutic target.

SCIENCE TRANSLATIONAL MEDICINE (2023)

添加到收藏夹

Review Cell Biology

Ephrin-Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies

Sowmya Mekala et al.

Summary: Hepatic fibrosis is a common pathological change caused by increased synthesis and accumulation of extracellular matrix components. Chronic insult from hepatotoxicants leads to liver cirrhosis and if not treated in time, liver transplantation is the only effective therapy. Moreover, the disease often progresses into hepatic carcinoma. Understanding the novel molecular signaling mechanisms involved in the disease progression would help develop effective therapeutics.

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2023)

添加到收藏夹

Review Medicine, General & Internal

An update on animal models of liver fibrosis

ShuTing Wu et al.

Summary: The development of liver fibrosis greatly impacts quality of life and prognosis. Animal models are commonly used to study the underlying mechanisms of human disease, as current organoid technology faces challenges. There are five categories of in vivo liver fibrosis models based on etiology: chemical, dietary, surgical, transgenic, and immune. The efficacy of these animal models varies, with different implications for understanding the disease and screening therapeutic agents. Currently, there is no high-quality literature recommending the most suitable animal models. This paper will provide an overview of commonly used animal models of liver fibrosis, including their development mechanisms, applications, advantages, and disadvantages, as well as recommend appropriate models for different research purposes.

FRONTIERS IN MEDICINE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Tetracycline antibiotics: Potential anticancer drugs

Jiayu Li et al.

Summary: In recent years, research on tetracycline antibiotics has shifted towards their anticancer effects. Doxycycline, minocycline, and tigecycline, approved by the FDA, have been the main focus. Evidence suggests that they can control cancer progression through various mechanisms such as anti-proliferation, anti-metastasis, and promotion of autophagy or apoptosis. These antibiotics can also be used in combination with other drugs to improve patient survival. This article introduces their mechanisms of action in different cancers, discusses combination therapies, and briefly summarizes research gaps and potential directions.

EUROPEAN JOURNAL OF PHARMACOLOGY (2023)

添加到收藏夹

Review Oncology

Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications

Stavros P. Papadakos et al.

Summary: This narrative literature review focuses on the role of EPH/ephrin signaling in liver cancer and its implications for tumor progression and potential therapeutic strategies. It highlights the upregulation of HIF-1α in HCC cells under low oxygen conditions and explores the significance of the EPH/ephrin axis in regulating the hypoxic tumor microenvironment. The review also emphasizes the potential of targeting the EPH/ephrin signaling pathway in liver cancer treatment.

CANCERS (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Hepatic fibrosis: 2022 Unmet needs and a blueprint for the future

Scott L. Friedman et al.

Summary: Steady progress has been made in understanding the pathogenesis and clinical consequences of hepatic fibrosis, but effective antifibrotic drugs are yet to be approved. This article highlights the successes and identifies gaps and unmet needs in both experimental and clinical aspects. Clarifying the mechanisms of fibrosis regression and developing better models will expedite drug development, while improving diagnostics and utilizing digital pathology methods can enhance prognostic information and better quantify therapeutic responses.

HEPATOLOGY (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications

Jose Garrido-Mesa et al.

Summary: Drug repurposing is a successful method to address the lack of cost-effective therapies in situations like the COVID-19 pandemic. Tetracyclines have shown efficacy in preclinical models of acute respiratory distress syndrome (ARDS) and have potential as an antiviral against SARS-CoV2. Despite limited scientific evidence, the multi-target pharmacology and safety profile of tetracyclines overcome limitations such as antibiotic activity and low commercial interest. Immunomodulatory tetracyclines and novel chemically modified non-antibiotic tetracyclines show therapeutic potential, and further drug repurposing studies in ARDS and severe COVID-19 are necessary.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2022)

添加到收藏夹

Article Ecology

Recovery of gut microbiota in mice exposed to tetracycline hydrochloride and their correlation with host metabolism

Wei Zhao et al.

Summary: Antibiotic exposure can change gut microbial community and host metabolism, with effects being reversible at low levels except for antibiotic resistance genes. Effective consideration and control of antibiotic dosage are important during application.

ECOTOXICOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain

Mahmoud S. Ahmed et al.

Summary: Previous studies showed that tetracycline antibiotics demeclocycline, chlortetracycline, and minocycline can inhibit EphB1 kinase activity, which was further confirmed in vivo by inhibiting phosphorylation of EphB1 in mice and effectively blocking neuropathic pain. This suggests that these drugs could be repurposed for treating neuropathic pain and potentially other conditions that benefit from inhibition of EphB1 receptor kinase activity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

The Development of Third-Generation Tetracycline Antibiotics and New Perspectives

Aura Rusu et al.

Summary: The tetracycline antibiotic class has introduced new valuable members such as tigecycline, omadacycline, eravacycline, and sarecycline, which have excellent development potential. These modern tetracyclines have a broad antibacterial spectrum and are effective in treating conditions like acne. The class continues to be of interest to researchers for both antibiotic and other biological effects, with new derivatives being developed.

PHARMACEUTICS (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Kinase drug discovery 20 years after imatinib: progress and future directions

Philip Cohen et al.

Summary: Advances in improving the potency and specificity of small-molecule protein kinase inhibitors over the past 20 years have had a significant impact on the treatment of cancers and non-cancerous conditions. Efforts are being made to address the challenge of drug resistance to kinase inhibitors, and future directions in kinase drug discovery are being discussed.

NATURE REVIEWS DRUG DISCOVERY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Molecular and cellular mechanisms of liver fibrosis and its regression

Tatiana Kisseleva et al.

Summary: Chronic liver injury results in liver inflammation and fibrosis, which can be reversed by eliminating activated myofibroblasts and resorbing the fibrous scar. Understanding the molecular mechanisms underlying liver fibrosis and its reversibility can lead to the identification of new therapeutic targets for liver fibrosis treatment.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

添加到收藏夹

Article Cell Biology

Synergistic antifibrotic effects of miR-451 with miR-185 partly by co-targeting EphB2 on hepatic stellate cells

Xiaogang Chen et al.

CELL DEATH & DISEASE (2020)

添加到收藏夹

Article Rheumatology

Ephrins and Eph Receptor Signaling in Tissue Repair and Fibrosis

Brian Wu et al.

CURRENT RHEUMATOLOGY REPORTS (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Eph receptor signalling: from catalytic to non-catalytic functions

Lung-Yu Liang et al.

ONCOGENE (2019)

添加到收藏夹

Article Multidisciplinary Sciences

EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells

Patrice N. Mimche et al.

SCIENTIFIC REPORTS (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Hepatic stellate cells as key target in liver fibrosis

Takaaki Higashi et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

The Cellular Thermal Shift Assay: A Novel Biophysical Assay for In Situ Drug Target Engagement and Mechanistic Biomarker Studies

Daniel Martinez Molina et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)

添加到收藏夹

Review Cell Biology

Mechanisms of ephrin-Eph signalling in development, physiology and disease

Artur Kania et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

New Insight into the Anti-liver Fibrosis Effect of Multitargeted Tyrosine Kinase Inhibitors: From Molecular Target to Clinical Trials

Kai Qu et al.

FRONTIERS IN PHARMACOLOGY (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Eph Receptors and Ephrins: Therapeutic Opportunities

Antonio Barquilla et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)

添加到收藏夹

Editorial Material Gastroenterology & Hepatology

Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis

Noah S. Butler et al.

HEPATOLOGY (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice

Patrice N. Mimche et al.

HEPATOLOGY (2015)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Therapeutic targeting of EPH receptors and their ligands

Andrew W. Boyd et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

添加到收藏夹

Review Pharmacology & Pharmacy

Minocycline: far beyond an antibiotic

N. Garrido-Mesa et al.

BRITISH JOURNAL OF PHARMACOLOGY (2013)

添加到收藏夹

Review Cell Biology

Eph/ephrin signaling: Genetic, phosphoproteomic, and transcriptomic approaches

Jeffrey O. Bush et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)

添加到收藏夹

Article Toxicology

Anti-inflammatory properties of Doxycycline and Minocycline in experimental models: an in vivo and in vitro comparative study

Liz M. Leite et al.

INFLAMMOPHARMACOLOGY (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ligand docking and binding site analysis with PyMOL and Autodock/Vina

Daniel Seeliger et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)

添加到收藏夹

Review Microbiology

Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance

I Chopra et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2001)

添加到收藏夹

Article Biochemistry & Molecular Biology

Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of eph receptors

KL Binns et al.

MOLECULAR AND CELLULAR BIOLOGY (2000)

添加到收藏夹

Article Biochemistry & Molecular Biology

Replacing two conserved tyrosines of the EphB2 receptor with glutamic acid prevents binding of SH2 domains without abrogating kinase activity and biological responses

AH Zisch et al.

ONCOGENE (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.